SEC Form 4 · accession 0001104659-18-045773
Rubius Therapeutics, Inc. · RUBY
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David R Epstein
Director
Period of report
Jul 17, 2018
Accepted (ET)
Jul 18, 2018 · 4:33 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001709401
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $23.00 | Jul 17, 2018 | A | 1,902,977 | A | — | Jul 16, 2028 | Common Stock | 1,902,977 | 1,902,977 | D |
Explanation of responses
- F1This option shall vest and become exercisable in full on the third anniversary of the date of grant.